BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Luo Y, Teng F, Fu H, Ding GS. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World J Gastrointest Oncol 2022; 14(1): 163-180 [PMID: 35116109 DOI: 10.4251/wjgo.v14.i1.163]
URL: https://www.wjgnet.com/1948-5204/full/v14/i1/163.htm
Number Citing Articles
Arno Kornberg, Linda Kaschny, Jennifer Kornberg, Helmut Friess. Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver TransplantationJournal of Hepatocellular Carcinoma 2022; : 649 doi: 10.2147/JHC.S366107
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A ReviewInternational Journal of Molecular Sciences 2023; 24(3): 2358 doi: 10.3390/ijms24032358
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti. Main factors influencing long-term outcomes of liver transplantation in 2022World Journal of Hepatology 2023; 15(3): 321-352 doi: 10.4254/wjh.v15.i3.321
Luyu Li, Yaorui Hu, Xiao Li, Baojun Ju. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A reviewMedicine 2024; 103(15): e37688 doi: 10.1097/MD.0000000000037688
Xiufeng Liu, Yinying Lu, Weiping Zhou, Tao Peng, Jie Zhou, Huaqiang Bi, Feng Xia, Xiaoping Chen. Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)Liver Cancer 2024; : 1 doi: 10.1159/000535496
Carrie E. Ryan, Jacob Lambdin, Shimul Shah, Ralph Cutler Quillin, Kristina Lemon, Jonathan M. Hernandez, Davendra Sohal. Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantAnnals of Surgical Oncology 2023; 30(2): 686 doi: 10.1245/s10434-022-12811-7
Parissa Tabrizian, Marcus Zeitlhoefler, Ahmed Talaat Hassan, Rebecca Marino. Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapyCurrent Opinion in Organ Transplantation 2024; 29(2): 144 doi: 10.1097/MOT.0000000000001133
Francesca Salani, Virginia Genovesi, Caterina Vivaldi, Valentina Massa, Silvia Cesario, Laura Bernardini, Miriam Caccese, Jessica Graziani, Dario Berra, Lorenzo Fornaro, Gianluca Masi. Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the HurdleCancers 2022; 14(19): 4896 doi: 10.3390/cancers14194896
Maciej Gryziak, Krzysztof Wozniak, Leszek Kraj, Letycja Rog, Rafal Stec. The immune landscape of hepatocellular carcinoma‑where we are? (Review)Oncology Letters 2022; 24(5) doi: 10.3892/ol.2022.13530
Experimental and Clinical Transplantation 2024; 22(2) doi: 10.6002/ect.2023.0342
Kevin Tak-Pan Ng, Jiang Liu, Oscar Wai-Ho Yeung, Li Pang, Hoi Chung Shiu, Hui Liu, Xin Xiang Yang, Albert Chi-Yan Chan, Tiffany Cho-Lam Wong, Chung Mau Lo, Kwan Man. Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinomaHepatology International 2023; 17(6): 1596 doi: 10.1007/s12072-023-10566-1
Wanyue Cao, Jing Lu, Shanbao Li, Fangbin Song, Junming Xu. Transcriptomic analysis of graft liver provides insight into the immune response of rat liver transplantationFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.947437
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, Emmanouil Sinakos. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantationWorld Journal of Transplantation 2022; 12(11): 331-346 doi: 10.5500/wjt.v12.i11.331